Catalyst Wire Dossier Catalyst Wire Dossier

Biphasic insulin aspart

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Biphasic insulin aspart, covering 2013-06-28 to 2018-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan [Phase 3]

See pricing